Skip to main content
Clinical Trials/NCT02705911
NCT02705911
Completed
Not Applicable

Isometric Handgrip Exercise: a New Non-pharmacological Tool in the Management of High Blood Pressure?

KU Leuven1 site in 1 country60 target enrollmentApril 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
KU Leuven
Enrollment
60
Locations
1
Primary Endpoint
change in office blood pressure at 8 weeks of follow-up
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this RCT which will be performed in 60 healthy adults is I. To assess the training effects of 8 weeks of isometric handgrip exercise on BP; and to test whether it yields at least similar effects on BP compared to current exercise recommendations.

II. To assess whether isometric handgrip training yields larger BP reductions beyond the supervised training period at 6 months of follow-up.

III. To determine whether changes in BP following acute exercise and chronic training can be explained by changes in important physiological mechanisms known to mediate or to be associated with BP?

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
July 2016
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Véronique Cornelissen

PhD

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • not physically active (\< 3 hours of moderate to high levels of PA/week) low cardiovascular risk according to current guidelines (Mancia et al J Hypertens 2013) will be recruited through advertisements. The latter is defined as:
  • \>115 mmHg \< systolic BP \< 139 mmHg and/or 75 mmHg\< diastolic BP\<90mmHg in the presence of 0 to a maximum of three other cardiovascular risk factors, excluding diabetes Or
  • 139 mmHg \< systolic BP \< 160 mmHg and/or 90 mmHg\<DBP\< 100 mmHg in the absence of other cardiovascular risk factors

Exclusion Criteria

  • current smoker
  • pregnancy
  • presence of other cardiovascular disease, pulmonary disease or metabolic disease
  • inability to perform a standard exercise program due to mental/physical disability.
  • use of antihypertensive drugs

Outcomes

Primary Outcomes

change in office blood pressure at 8 weeks of follow-up

Time Frame: 8 weeks - 6 months

Secondary Outcomes

  • change in exercise tolerance (peakVO2 in ml/min/kg) at 8 weeks of follow-up(8 weeks - 6 months)

Study Sites (1)

Loading locations...

Similar Trials